The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic

Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis (HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic. Methods We evaluated characteristics, laboratory parameters, and outcomes in hospitalized HD patients with COVID‐19 (n = 102)...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic apheresis and dialysis 2023-08, Vol.27 (4), p.701-710
Main Authors: Banshodani, Masataka, Kawanishi, Hideki, Hirai, Takayuki, Kawai, Yusuke, Hashimoto, Shinji, Shintaku, Sadanori, Moriishi, Misaki, Marubayashi, Seiji, Tsuchiya, Shinichiro
Format: Article
Language:English
Subjects:
CCL17
COVID-19 - therapy
COVID‐19
hemodialysis
Humans
Multivariate Analysis
Omicron variant
Renal Dialysis
SARS‐CoV‐2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis (HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic. Methods We evaluated characteristics, laboratory parameters, and outcomes in hospitalized HD patients with COVID‐19 (n = 102) at two centers between January and April 2022. Results The 30‐day mortality rate was higher in moderate–critical group (n = 43) than mild group (n = 59) (16.3% vs. 1.7%; p = 0.007), and higher in patients with lower CC chemokine ligand 17 (CCL17) levels (
ISSN:1744-9979
1744-9987
DOI:10.1111/1744-9987.13970